πŸ‡ΊπŸ‡Έ FDA
Patent

US 12357705

Negatively charged peg-lipid conjugates

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 12357705 (Negatively charged peg-lipid conjugates) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7105, A61K31/713, A61K47/543, A61K47/60